Literature DB >> 17516479

Determinants of quality of life in Brazilian patients with Parkinson's disease.

Francisco Javier Carod-Artal1, Antonio Pedro Vargas1, Pablo Martinez-Martin2.   

Abstract

Our objective was to identify determinants of health-related quality of life (HRQoL) in a cohort of Brazilian patients with Parkinson's disease (PD). Patients were evaluated by means of the Hoehn and Yahr staging (H&Y), Unified Parkinson's Disease Rating Scale (UPDRS), Schwab and England scale (S&E), Mini-Mental State Exam, Geriatric Depression Scale, and Hospital Anxiety and Depression Scale (HADS). HRQol was assessed using the MOS-Short-Form 36 (SF-36), the Parkinson's disease Questionnaire (PDQ-39), and the Scales for Outcomes in Parkinson's Disease-Psychosocial Questionnaire (SCOPA-PS). 144 patients were evaluated (mean age 62 years; 53.5% men; mean duration of illness 6.6 years; median H&Y, 2 (range: 1-4). Mean SCOPA-PS and PDQ-39 Summary Index (SI) were 39.2 and 40.7, respectively. Both, PDQ-39 and SCOPA-PS SIs correlated at a moderate level (r = 0.30-0.50) with H&Y, S&E, total UPDRS, HADS subscales, and SF-36 Physical and Mental Components. PDQ-39 and SCOPA-PS were closely associated (r = 0.73). HRQoL significantly deteriorated as H&Y progressed, as a whole. Mood disturbances, disability, motor complications, and education were independent predictors of HRQoL in the multivariate analysis model. In PD Brazilian patients, HRQoL correlated significantly with diverse measures of severity. Depression showed to be the most consistent determinant of HRQoL, followed by disability, motor complications, and education years. There was a close association between the PDQ-39 and SCOPA-PS summary scores. Copyright 2007 Movement Disorder Society

Entities:  

Mesh:

Year:  2007        PMID: 17516479     DOI: 10.1002/mds.21408

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  24 in total

1.  Mood and motor trajectories in Parkinson's disease: multivariate latent growth curve modeling.

Authors:  Laura B Zahodne; Michael Marsiske; Michael S Okun; Ramon L Rodriguez; Irene Malaty; Dawn Bowers
Journal:  Neuropsychology       Date:  2011-12-05       Impact factor: 3.295

2.  Health-related quality of life of australians with Parkinson disease: a comparison with international studies.

Authors:  Sze-Ee Soh; Jennifer L McGinley; Jennifer J Watts; Robert Iansek; Meg E Morris
Journal:  Physiother Can       Date:  2012       Impact factor: 1.037

3.  Personality and reported quality of life in Parkinson's disease.

Authors:  Gregory M Pontone; Zoltan Mari; Kate Perepezko; Howard D Weiss; Susan S Bassett
Journal:  Int J Geriatr Psychiatry       Date:  2016-04-05       Impact factor: 3.485

4.  The role of dispositional mindfulness in a stress-health pathway among Parkinson's disease patients and caregiving partners.

Authors:  Allison Hicks; Kala Phillips; Chelsea Siwik; Paul Salmon; Irene Litvan; Megan E Jablonski; J Vincent Filoteo; Karen Kayser; Sandra E Sephton
Journal:  Qual Life Res       Date:  2019-06-14       Impact factor: 4.147

5.  Health-related quality of life in Parkinson disease: correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veterans.

Authors:  Galit Kleiner-Fisman; Matthew B Stern; David N Fisman
Journal:  Health Qual Life Outcomes       Date:  2010-08-30       Impact factor: 3.186

6.  Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study.

Authors:  Yaroslav Winter; Sonja von Campenhausen; Julia Gasser; Klaus Seppi; Jens-P Reese; Karl-P Pfeiffer; Kai Bötzel; Wolfgang H Oertel; Richard Dodel; Werner Poewe
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

Review 7.  Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease.

Authors:  David A Gallagher; Anette Schrag
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

8.  Gender-related differences in the burden of non-motor symptoms in Parkinson's disease.

Authors:  Pablo Martinez-Martin; Cristian Falup Pecurariu; Per Odin; Jacobus J van Hilten; Angelo Antonini; Jose M Rojo-Abuin; Vanderci Borges; Claudia Trenkwalder; Dag Aarsland; David J Brooks; Kallol Ray Chaudhuri
Journal:  J Neurol       Date:  2012-01-12       Impact factor: 4.849

9.  Neurologists' diagnostic accuracy of depression and cognitive problems in patients with parkinsonism.

Authors:  Angela E P Bouwmans; Wim E J Weber
Journal:  BMC Neurol       Date:  2012-06-15       Impact factor: 2.474

10.  Health-related quality of life in Parkinson's disease: a cross-sectional study focusing on non-motor symptoms.

Authors:  Liis Kadastik-Eerme; Marika Rosenthal; Tiiu Paju; Mari Muldmaa; Pille Taba
Journal:  Health Qual Life Outcomes       Date:  2015-06-20       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.